ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

EPGNY Epigenomics AG (QX)

2.39
0.00 (0.00%)
Mar 27 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0.00
Bid Price 1.73
Ask Price 469,205.12
News -
Company Name Stock Ticker Symbol Market Type
Epigenomics AG (QX) EPGNY OTCMarkets Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 2.39 20:00:00
Open Price Low Price High Price Close Price Prev Close
2.39 2.39
Trades Volume Avg Volume
0 0.00 -
Last Trade Time Type Quantity Stock Price Currency
- 0  2.39 USD

Epigenomics AG (QX) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 9.78M 4.09M 2.93M - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Epigenomics (QX)

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No EPGNY Message Board. Create One! See More Posts on EPGNY Message Board See More Message Board Posts

EPGNY Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

Epigenomics is a molecular diagnostics company focused on blood-based detection of cancers using its proprietary DNA methylation biomarker technology. The company develops and commercializes diagnostic products across multiple cancer indications with high medical need. Epigenomics' lead product, Epi proColon, is a blood-based screening test for the detection of colorectal cancer. Epi proColon has received approval from the U.S. Food and Drug Administration (FDA) and is currently marketed in the United States, Europe, and China and selected other countries. Epi proLung, a test for lung cancer detection, and HCCBloodTest, a test for liver cancer, have received CE mark in Europe. For more information, visit www.epigenomics.com.

Your Recent History

Delayed Upgrade Clock